Biochemical markers of liver fibrosis in HCV patients

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Osteopontin as a potential biomarker for hepatocellular carcinoma

3 Biochemical markers in blood can predict cirrhotic evolution of chronic hepatitis

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Diagnostic and prognostic value of PIVK-II, TGF-beta-1, VEGF and AFP in the diagnosis of benign and malignant liver diseases

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma